Blog
RSS FeedPosted by Michael Wonder on 25 Jun 2020
Price disclosure October 2020 cycle outcomes summary
25 June 2020 - The summary of price disclosure price reductions for the October 2020 Cycle has now been published. ...
Posted by Michael Wonder on 22 Jun 2020
PMPRB publishes new draft guidelines, launches 30 day consultation
22 June 2020 - As reported earlier this month, the Patented Medicine Prices Review Board has published a new draft ...
Posted by Michael Wonder on 15 Jun 2020
The unprecedented challenge of pricing a coronavirus vaccine
12 June 2020 - The optimal pricing strategy for a new vaccine involves setting a fair and sustainable price that ...
Posted by Michael Wonder on 03 Jun 2020
Lower prices and greater patient access — lessons from Germany’s drug purchasing structure
3 June 2020 - The German system for determining drug prices features collective negotiations on the part of competing health plans. ...
Posted by Michael Wonder on 03 Jun 2020
How a US-UK trade agreement could affect NHS drug prices
1 June 2020 - The governments of the UK and US are working on the outlines of a trade agreement. ...
Posted by Michael Wonder on 01 Jun 2020
Canada's new drug price rules pushed to next year
1 June 2020 - Canada's drug pricing agency said on Monday that new regulations aimed at lowering costs would come ...
Posted by Michael Wonder on 26 May 2020
B.C. mom’s drug pricing petition on behalf of son garners thousands of signatures
26 May 2020 - Petition geared to gaining access to new medicines drew support of Chilliwack-Hope MP Mark Strahl. ...
Posted by Michael Wonder on 21 May 2020
Canada grapples with drug price escalation
20 May 2020 - In July 2020 Canada will implement a series of reforms to help bring runaway drug prices under ...
Posted by Michael Wonder on 03 May 2020
Canadian prescription drug prices come under scrutiny of U.S. trade representative
1 May 2020 - The United States is keeping Canada and its plans to overhaul its drug-pricing system on a ...
Posted by Michael Wonder on 28 Apr 2020
Spinraza could give teen a longer life, but Government says it's too expensive
28 April 2020 - A Greymouth father is battling for PHARMAC funding for a drug he hopes can help his ...
Posted by Michael Wonder on 31 Mar 2020
1 April 2020 price disclosure confirmed prices
31 March 2020 - Confirmed 1 April 2020 prices resulting from the 2020 April cycle of price disclosure have been published ...
Posted by Michael Wonder on 23 Mar 2020
Determinants of orphan drug prices in Germany
21 March 2020 - Legislation introduced in 2011 in Germany has instituted an early benefit assessment of newly licensed pharmaceuticals with ...
Posted by Michael Wonder on 19 Mar 2020
Low prices won't keep new medicines out of Canada
19 March 2020 - There is no evidence of a link between pricing, research and development, and access to medicine. ...
Posted by Michael Wonder on 08 Mar 2020
Price controls imposed by shortsighted politicians keep new life-saving drugs out
5 March 2020 - Politicians need to step outside the Ottawa bubble and understand how their policies impact the lives of ...
Posted by Michael Wonder on 05 Mar 2020
The U.S. has a problem with prescription drug prices. Canada shouldn’t try to fix it.
2 March 2020 - President Donald Trump and the U.S. Congress are scrambling to find ways to make medicines more ...